Document Detail


Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver.
MedLine Citation:
PMID:  2007411     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rat serum, in which the complement system had been activated by incubation with zymosan, increased the glucose and lactate output, and reduced and redistributed the flow in isolated perfused rat liver clearly more than the control serum. Heat inactivation of the rat serum prior to zymosan incubation abolished this difference. Metabolic and hemodynamic alterations caused by the activated serum were dose dependent. They were almost completely inhibited by the cyclooxygenase inhibitor indomethacin and by the thromboxane antagonist 4-[2-(4-chlorobenzesulfonamide)-ethyl]-benzene-acetic acid (BM 13505), but clearly less efficiently by the 5'-lipoxygenase inhibitor nordihydroguaiaretic acid and the leukotriene antagonist N-(3-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propoxy]-4-chlorine-6-meth yl- phenyl)-1H-tetrazole-5-carboxamide sodium salt (CGP 35949 B). Control serum and to a much larger extent complement-activated serum, caused an overflow of thromboxane B2 and prostaglandin F2 alpha into the hepatic vein. It is concluded that the activated complement system of rat serum can influence liver metabolism and hemodynamics via release from nonparenchymal liver cells of thromboxane and prostaglandins, the latter of which can in turn act on the parenchymal cells.
Authors:
W Muschol; G P Püschel; M Hülsmann; K Jungermann
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of biochemistry / FEBS     Volume:  196     ISSN:  0014-2956     ISO Abbreviation:  Eur. J. Biochem.     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-04-26     Completed Date:  1991-04-26     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0107600     Medline TA:  Eur J Biochem     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  525-30     Citation Subset:  IM    
Affiliation:
Institut für Biochemie, Georg-August-Universität Göttingen, Federal Republic of Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
Complement Activation / drug effects*
Complement Inactivator Proteins / pharmacology
Complement Pathway, Alternative / physiology
Dinoprost / antagonists & inhibitors,  blood
Eicosanoids / biosynthesis*,  pharmacology
Glucose / metabolism*
Hemodynamics / drug effects
Hot Temperature
Lactates / metabolism*
Lactic Acid
Liver / metabolism*
Male
Rats
Rats, Inbred Strains
Thromboxane B2 / antagonists & inhibitors,  blood
Zymosan / pharmacology
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Complement Inactivator Proteins; 0/Eicosanoids; 0/Lactates; 50-21-5/Lactic Acid; 50-99-7/Glucose; 54397-85-2/Thromboxane B2; 551-11-1/Dinoprost; 9010-72-4/Zymosan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-chain-acyl-CoA synthetase and very-long-chain-acyl-CoA synthetase activities in peroxisomes and...
Next Document:  Clinicopathological study of upper urinary tract tumors associated with bladder tumors.